PURE Bioscience, Announces Inc. (OTCQB: PURE) (“PURE,” the “Company,” or “we”), the developer of a patented non-toxic silver dihydrogen citrate (SDC) antimicrobial technology, announced its financial results for the fiscal third quarter ended April 30, 2025. Alongside its financial disclosures, the Company highlighted key operational achievements and strategic initiatives focused on expanding the commercial use of its innovative antimicrobial solutions—particularly within the dairy and beverage sectors.
Financial Performance Overview: Fiscal Third Quarter 2025
In the fiscal third quarter of 2025, PURE Bioscience generated net product sales of $489,000, marking a year-over-year increase of $49,000, or approximately 11%, compared to $440,000 in the same quarter of fiscal 2024. The increase in revenue reflects the ongoing traction PURE is achieving across its distribution network and among direct customers, signaling steady progress in customer adoption of its antimicrobial technologies.
The net loss for the fiscal third quarter narrowed to $580,000, compared to a net loss of $857,000 for the same period in the previous year—a 32% improvement. This reduction in net loss is attributed to PURE’s continued efforts to manage and lower operating expenses while maintaining focus on product development and commercialization efforts. Excluding share-based compensation expenses, the adjusted net loss for the quarter was $547,000, an improvement from $825,000 reported in Q3 2024.
Earnings per share remained consistent year-over-year at a net loss of ($0.01) per share for both fiscal Q3 2025 and Q3 2024.
Financial Performance Overview: Nine Months Ended April 30, 2025
For the nine-month period ended April 30, 2025, PURE reported total net product sales of $1,435,000 compared to $1,483,000 for the corresponding nine-month period in 2024, reflecting a modest decline of $48,000. This slight decrease was attributed to reduced demand across certain end-user networks, although the Company continues to strengthen its position within targeted market segments.
Despite the dip in sales, PURE reduced its net loss to $2,067,000 during the nine-month period, representing a significant improvement over the $2,594,000 loss recorded in the same period of fiscal 2024. Excluding share-based compensation, the adjusted net loss was $1,950,000, compared to $2,418,000 in the prior year.
Earnings per share also showed improvement, with a reduced net loss per share of ($0.02) for the nine months ended April 30, 2025, compared to ($0.03) during the same timeframe in the previous year.
Operational Highlights and Strategic Developments
PURE Bioscience made significant strides in commercial validation during the third quarter, most notably in the application of its proprietary silver dihydrogen citrate (SDC) technology within commercial dairy operations.
Robert Bartlett, Chief Executive Officer of PURE, emphasized the significance of this progress, stating:
“Our fiscal third quarter year-over-year sales growth continues to progress with our direct customers and distribution network, while we continue to reduce operating expenses. This quarter, we were able to demonstrate that our dairy membrane solution using our SDC technology is effective in full-scale commercial dairy plants. We will continue to work closely with our distribution partners in the beverage industry to expand this new membrane treatment solution.”
The application of SDC in membrane treatment marks an important evolution for PURE’s product portfolio. As a component of the PURE Hard Surface product line, the membrane treatment solution offers an efficient and safe alternative to conventional cleaning agents used in dairy and beverage manufacturing facilities. By integrating PURE’s antimicrobial into cleaning protocols, producers can achieve higher levels of hygiene and pathogen control, all while reducing downtime and extending membrane life—key factors in optimizing plant performance.
PURE Hard Surface: A Game-Changer in Membrane Treatment
Now available for membrane treatment, PURE Hard Surface introduces a cutting-edge solution designed to address longstanding challenges in dairy and beverage production. Traditionally, membrane systems used in these sectors require frequent, chemically intensive cleaning cycles that often lead to equipment degradation, increased labor costs, and potential product contamination.
PURE Hard Surface, formulated with the Company’s signature SDC antimicrobial, provides a powerful yet non-toxic option. The technology offers broad-spectrum efficacy against bacteria, viruses, and fungi without contributing to antimicrobial resistance—a growing concern within the food processing and healthcare industries.
This next-generation membrane treatment delivers measurable benefits, including:
- Reduced frequency of cleaning cycles
- Extended membrane lifespan
- Lower operational costs
- Improved regulatory compliance and food safety standards
Manufacturers can now achieve a more consistent and reliable hygienic environment while reducing their environmental footprint. More information on PURE Hard Surface’s application in membrane treatment can be found at
Commitment to Innovation and Public Health
PURE Bioscience remains steadfast in its mission to redefine chemical safety across industries through its advanced antimicrobial technology. The Company continues to prioritize innovation and regulatory compliance in the development of products that promote both public health and environmental sustainability.
At the heart of PURE’s innovation is its patented silver dihydrogen citrate (SDC) platform—an ionic silver-based antimicrobial that offers a safer alternative to conventional disinfectants. Unlike traditional chemical disinfectants that often pose toxicity risks or contribute to microbial resistance, SDC is non-toxic, long-lasting, and effective against a wide spectrum of pathogens.
PURE’s technology is especially well-suited for food safety applications, a core focus area for the Company. The SDC formulation is approved for use in various settings, including food contact surfaces, and continues to gain interest from food and beverage producers seeking to improve hygiene and safety without compromising operational efficiency.
